227 related articles for article (PubMed ID: 22343626)
1. Refinement of structural leads for centrally acting oxime reactivators of phosphylated cholinesterases.
Radić Z; Sit RK; Kovarik Z; Berend S; Garcia E; Zhang L; Amitai G; Green C; Radić B; Fokin VV; Sharpless KB; Taylor P
J Biol Chem; 2012 Apr; 287(15):11798-809. PubMed ID: 22343626
[TBL] [Abstract][Full Text] [Related]
2. Mechanism of interaction of novel uncharged, centrally active reactivators with OP-hAChE conjugates.
Radić Z; Sit RK; Garcia E; Zhang L; Berend S; Kovarik Z; Amitai G; Fokin VV; Barry Sharpless K; Taylor P
Chem Biol Interact; 2013 Mar; 203(1):67-71. PubMed ID: 22975155
[TBL] [Abstract][Full Text] [Related]
3. Centrally acting oximes in reactivation of tabun-phosphoramidated AChE.
Kovarik Z; Maček N; Sit RK; Radić Z; Fokin VV; Barry Sharpless K; Taylor P
Chem Biol Interact; 2013 Mar; 203(1):77-80. PubMed ID: 22960624
[TBL] [Abstract][Full Text] [Related]
4. Rational design, synthesis, and evaluation of uncharged, "smart" bis-oxime antidotes of organophosphate-inhibited human acetylcholinesterase.
Gorecki L; Gerlits O; Kong X; Cheng X; Blumenthal DK; Taylor P; Ballatore C; Kovalevsky A; Radić Z
J Biol Chem; 2020 Mar; 295(13):4079-4092. PubMed ID: 32019865
[TBL] [Abstract][Full Text] [Related]
5. New structural scaffolds for centrally acting oxime reactivators of phosphylated cholinesterases.
Sit RK; Radić Z; Gerardi V; Zhang L; Garcia E; Katalinić M; Amitai G; Kovarik Z; Fokin VV; Sharpless KB; Taylor P
J Biol Chem; 2011 Jun; 286(22):19422-30. PubMed ID: 21464125
[TBL] [Abstract][Full Text] [Related]
6. A single post-exposure oxime RS194B treatment rapidly reactivates acetylcholinesterase and reverses acute symptoms in macaques exposed to diethylphosphorothioate parathion and chlorpyrifos insecticides.
Rosenberg YJ; Garcia K; Diener J; Sullivan D; Donahue S; Mao L; Lees J; Jiang X; Urban LA; Momper JD; Ho KY; Taylor P
J Neurochem; 2024 Apr; 168(4):370-380. PubMed ID: 36786545
[TBL] [Abstract][Full Text] [Related]
7. Interactions between xylene-linked carbamoyl bis-pyridinium mono-oximes and organophosphates inhibited-AChE: a kinetic study.
Sharma R; Gupta B; Acharya J; Kaushik MP; Ghosh KK
Toxicology; 2014 Feb; 316():1-8. PubMed ID: 24345352
[TBL] [Abstract][Full Text] [Related]
8. Post-exposure treatment with the oxime RS194B rapidly reactivates and reverses advanced symptoms of lethal inhaled paraoxon in macaques.
Rosenberg YJ; Wang J; Ooms T; Rajendran N; Mao L; Jiang X; Lees J; Urban L; Momper JD; Sepulveda Y; Shyong YJ; Taylor P
Toxicol Lett; 2018 Sep; 293():229-234. PubMed ID: 29129799
[TBL] [Abstract][Full Text] [Related]
9. Limitations in current acetylcholinesterase structure-based design of oxime antidotes for organophosphate poisoning.
Kovalevsky A; Blumenthal DK; Cheng X; Taylor P; Radić Z
Ann N Y Acad Sci; 2016 Aug; 1378(1):41-49. PubMed ID: 27371941
[TBL] [Abstract][Full Text] [Related]
10. Exploring the physicochemical properties of oxime-reactivation therapeutics for cyclosarin, sarin, tabun, and VX inactivated acetylcholinesterase.
Esposito EX; Stouch TR; Wymore T; Madura JD
Chem Res Toxicol; 2014 Jan; 27(1):99-110. PubMed ID: 24443939
[TBL] [Abstract][Full Text] [Related]
11. Counteracting tabun inhibition by reactivation by pyridinium aldoximes that interact with active center gorge mutants of acetylcholinesterase.
Kovarik Z; Maček Hrvat N; Kalisiak J; Katalinić M; Sit RK; Zorbaz T; Radić Z; Fokin VV; Sharpless KB; Taylor P
Toxicol Appl Pharmacol; 2019 Jun; 372():40-46. PubMed ID: 30978400
[TBL] [Abstract][Full Text] [Related]
12. Potent 3-Hydroxy-2-Pyridine Aldoxime Reactivators of Organophosphate-Inhibited Cholinesterases with Predicted Blood-Brain Barrier Penetration.
Zorbaz T; Braïki A; Maraković N; Renou J; de la Mora E; Maček Hrvat N; Katalinić M; Silman I; Sussman JL; Mercey G; Gomez C; Mougeot R; Pérez B; Baati R; Nachon F; Weik M; Jean L; Kovarik Z; Renard PY
Chemistry; 2018 Jul; 24(38):9675-9691. PubMed ID: 29672968
[TBL] [Abstract][Full Text] [Related]
13. Influence of gauche effect on uncharged oxime reactivators for the reactivation of tabun-inhibited AChE: quantum chemical and steered molecular dynamics studies.
Ghosh S; Jana K; Ganguly B
J Comput Aided Mol Des; 2018 Jul; 32(7):793-807. PubMed ID: 29980922
[TBL] [Abstract][Full Text] [Related]
14. A common mechanism for resistance to oxime reactivation of acetylcholinesterase inhibited by organophosphorus compounds.
Maxwell DM; Brecht KM; Sweeney RE
Chem Biol Interact; 2013 Mar; 203(1):72-6. PubMed ID: 22982773
[TBL] [Abstract][Full Text] [Related]
15. Testing of novel brain-penetrating oxime reactivators of acetylcholinesterase inhibited by nerve agent surrogates.
Chambers JE; Chambers HW; Meek EC; Pringle RB
Chem Biol Interact; 2013 Mar; 203(1):135-8. PubMed ID: 23123249
[TBL] [Abstract][Full Text] [Related]
16. Structural requirements for effective oximes--evaluation of kinetic in vitro data with phosphylated human AChE and structurally different oximes.
Worek F; Wille T; Koller M; Thiermann H
Chem Biol Interact; 2013 Mar; 203(1):125-8. PubMed ID: 22827894
[TBL] [Abstract][Full Text] [Related]
17. Cholinesterase reactivators: the fate and effects in the organism poisoned with organophosphates/nerve agents.
Bajgar J; Kuca K; Jun D; Bartosova L; Fusek J
Curr Drug Metab; 2007 Dec; 8(8):803-9. PubMed ID: 18220560
[TBL] [Abstract][Full Text] [Related]
18. Post-exposure treatment with the oxime RS194B rapidly reverses early and advanced symptoms in macaques exposed to sarin vapor.
Rosenberg YJ; Mao L; Jiang X; Lees J; Zhang L; Radic Z; Taylor P
Chem Biol Interact; 2017 Aug; 274():50-57. PubMed ID: 28693885
[TBL] [Abstract][Full Text] [Related]
19. Interactions between acetylcholinesterase, toxic organophosphorus compounds and a short series of structurally related non-oxime reactivators: Analysis of reactivation and inhibition kinetics in vitro.
Horn G; de Koning MC; van Grol M; Thiermann H; Worek F
Toxicol Lett; 2018 Dec; 299():218-225. PubMed ID: 30312685
[TBL] [Abstract][Full Text] [Related]
20. Oxime-assisted reactivation of tabun-inhibited acetylcholinesterase analysed by active site mutations.
Katalinić M; Šinko G; Maček Hrvat N; Zorbaz T; Bosak A; Kovarik Z
Toxicology; 2018 Aug; 406-407():104-113. PubMed ID: 29772260
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
